Bill Gates buys Anheuser-Busch shares during Bud Light slump
Bill Gates has made a US$95 million bet on AB InBev after buying Anheuser-Busch shares amid the business’s troubles with its Bud Light brand.
According to reports highlighting details from a regulatory filing, last quarter the Bill and Melinda Gates Foundation Trust bought 1.7 million Anheuser-Busch shares valued at around US$95 million. The timing of the stock being bought was reported to be around the time AB InBev reported earnings that encompassed its Bud Light brand falling from favour.
Despite Gates’ move signalling his confidence in the company, so far the trust has lost money on his investment with the Anheuser-Busch stock reportedly being down nearly 2% since it was bought and now showing a nosedive of approximately 7% for the year.
Last month, AB InBev also revealed that its US revenue plummeted 10% in the second quarter, impacted by falling Bud Light sales and in July began laying off hundreds of workers across its US corporate staff.
Incidentally, this is not Gates’ only investment into beer this year. In February, the Microsoft billionaire spent €850 million on a 3.76% stake in Heineken, despite admitting he is “not a big beer drinker”.
Related news
Moscow blocks deals between Anatolian Efes and AB InBev
Moscow has blocked a deal that would have allowed Turkish…
Read more >Retail trade and FMCG have become more attractive to workers
On 25 April Randstad Magyarország published the list of Hungary’s…
Read more >Heineken Balaton Sound starts on July 3
After its return in 2023, Heineken will once again join…
Read more >Related news
A new office responsible for food safety and retail trade can be established under the leadership of Márton Nagy
A new top organization called the National Trade Office could…
Read more >K&H: Almost two-thirds of businesses are planning development
The majority of domestic micro, small and medium-sized enterprises, 61…
Read more >KSH: industrial production fell by 8.2 percent in June
In June 2024, the volume of industrial production was 8.2…
Read more >